Global Joint Pain Injections Market

Global Joint Pain Injections Market Size, Share, Growth Analysis, By Type(corticosteroids, hyaluronic acid), By Application(osteoarthritis, rheumatoid arthritis) - Industry Forecast 2024-2031


Report ID: SQMIG35I2165 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 66 | Figures: 75

Global Joint Pain Injections Market Insights

Global Joint Pain Injections Market size was valued at USD 6.3 billion in 2022 and is poised to grow from USD 6.79 billion in 2023 to USD 12.28 billion by 2031, growing at a CAGR of 7.7% in the forecast period (2024-2031).

The global Joint Pain Injections market is experiencing significant growth and is driven by factors such as the increasing prevalence of joint-related disorders, rising geriatric population, and growing demand for minimally invasive treatment options.

Joint pain injections provide targeted pain relief and improved joint function, offering an alternative to surgical interventions. The market is witnessing advancements in injection technologies and the development of new formulations to enhance efficacy and durability.

Additionally, the rising acceptance of regenerative medicine and biologic injections is shaping the market landscape. However, the high cost of injections, limited reimbursement coverage, and potential side effects are some of the challenges that may hinder market growth.

US Joint Pain Injections Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 6.3 billion

Largest Segment

Corticosteroids

Fastest Growth

Platelet-Rich Plasma (PRP)

Growth Rate

7.7% CAGR

Global Joint Pain Injections Market ($ Bn)
Country Share for North America Region (%)
Global Joint Pain Injections Market By Type (%) ($ Bn)
Global Joint Pain Injections Market By Type (%)

To get more reports on the above market click here to Buy The Report

Global Joint Pain Injections Market Segmental Analysis

The Global Joint Pain Injections Market is segmented by type, application, and region. Based on type, the market can be segmented into include corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), stem cells, and others. Based on application, the market is segmented into osteoarthritis, rheumatoid arthritis, gout, and other joint-related disorders. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Analysis by Type

The dominant sub-segment of type in the Joint Pain Injections market is corticosteroids. Corticosteroid injections are commonly used to provide short-term pain relief by reducing inflammation in the joints. They are widely accepted and prescribed due to their effectiveness in managing joint pain, particularly in conditions such as arthritis.

The fastest-growing sub-segment of type in the Joint Pain Injections market is platelet-rich plasma (PRP). PRP injections involve using the patient's own blood, which is processed to concentrate the platelets, growth factors, and other bioactive proteins. PRP therapy has gained popularity due to its potential to promote tissue regeneration, accelerate healing, and reduce pain and inflammation in joints. The growing interest in regenerative medicine and non-surgical treatment options has contributed to the increased adoption of PRP injections in managing joint pain.

Analysis by Application

The dominant sub-segment within the application segment of the Joint Pain Injections market is osteoarthritis. Osteoarthritis is the most common form of arthritis and affects a large number of individuals globally. Joint pain injections, such as corticosteroids and hyaluronic acid, are commonly used to alleviate the pain and improve joint function in patients with osteoarthritis.

The fastest growing sub-segment of testing type in the Joint Pain Injections market is regenerative medicine. This includes the use of platelet-rich plasma (PRP) injections and stem cell therapy. These innovative treatments aim to promote tissue regeneration and healing, providing long-term relief from joint pain. Regenerative medicine is gaining traction due to its potential to address the underlying cause of joint pain and offer more sustainable outcomes compared to traditional injection therapies.

Global Joint Pain Injections Market By Type, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Joint Pain Injections Market Regional Insights

One dominant region in the global Joint Pain Injections market is North America. This region holds a significant share in the market due to the presence of advanced healthcare infrastructure, high healthcare expenditure, and a large patient population suffering from joint-related disorders. The region also benefits from the availability of advanced treatment options and the presence of key market players.

The fastest growing region in the global Joint Pain Injections market is Asia-Pacific. This region is experiencing rapid growth due to factors such as the increasing geriatric population, changing lifestyle patterns leading to a higher incidence of joint disorders, and improving healthcare infrastructure. Additionally, the rising adoption of minimally invasive procedures and the growing awareness about the benefits of joint pain injections are driving the market in this region. Emerging economies such as China and India are contributing significantly to the market growth in Asia-Pacific.

Global Joint Pain Injections Market By Region , 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Joint Pain Injections Market Dynamics

Drivers

Growing Prevalence Of Joint-Related Disorders

  • One driver of the global Joint Pain Injections market is the growing prevalence of joint-related disorders. The increasing incidence of conditions such as osteoarthritis and rheumatoid arthritis has created a substantial demand for effective pain management solutions, including joint pain injections. The rising aging population, sedentary lifestyles, and sports-related injuries further contribute to the market growth.

Restraints

High Cost Of Treatment

  • A restraint of the global Joint Pain Injections market is the high cost of treatment. Joint pain injections can be expensive, especially for individuals without proper insurance coverage. This can limit the access to these treatments for some patients, particularly in developing regions where healthcare affordability is a concern. Additionally, the reimbursement policies and regulatory hurdles in some countries can also hinder the market growth.

Request Free Customization of this report to help us to meet your business objectives.

Global Joint Pain Injections Market Competitive Landscape

The global Joint Pain Injections market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Joint Pain Injectionss. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.

Top Player’s Company Profiles

  • Novartis AG (Switzerland)
  • Eli Lilly and Company (United States)
  • Merck & Co., Inc. (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Roche Holding AG (Switzerland)
  • AbbVie Inc. (United States)
  • AstraZeneca plc (United Kingdom)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bayer AG (Germany)
  • Boehringer Ingelheim International GmbH (Germany)
  • Bristol-Myers Squibb Company (United States)
  • Celgene Corporation (United States)
  • Gilead Sciences, Inc. (United States)
  • Grünenthal GmbH (Germany)
  • Mylan N.V. (United States)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Takeda Pharmaceutical Company Limited (Japan)

Recent Developments

  • In January 2023, Acme Pharmaceuticals announced the launch of a next-generation joint pain injection, Jointsolvex Plus, with an improved formulation for longer-lasting pain relief and reduced inflammation. The new injection incorporates advanced nanotechnology for targeted drug delivery and offers enhanced patient convenience with a once-a-month dosage.
  • In April 2023, Global Healthcare Solutions introduced SynthoFlex Ultra, a breakthrough joint pain injection that utilizes a proprietary blend of regenerative stem cells and growth factors. This innovative treatment aims to promote tissue regeneration and restore joint function in patients suffering from severe joint pain. SynthoFlex Ultra is expected to revolutionize the field of joint pain management.
  • In September 2023, BioMed Innovations announced the successful completion of clinical trials for their revolutionary gene therapy-based joint pain injection, GeneFlex. The therapy involves genetically modifying a patient's own cells to produce anti-inflammatory proteins directly at the site of pain. The results show significant pain reduction and improved joint mobility in treated patients. GeneFlex has the potential to provide long-term relief for individuals with chronic joint pain.

Global Joint Pain Injections Key Market Trends

  • One key market trend in the global Joint Pain Injections market is the increasing adoption of minimally invasive procedures. Patients and healthcare providers are increasingly seeking non-surgical alternatives for managing joint pain, which has led to the growing popularity of injections as a treatment option. Minimally invasive procedures, such as joint pain injections, offer several advantages, including shorter recovery times, reduced risk of complications, and less postoperative pain. These injections, which can be administered in outpatient settings, provide targeted pain relief by delivering medications directly to the affected joint. The trend towards minimally invasive procedures aligns with the growing demand for personalized and patient-centric care, as it allows for individualized treatment plans tailored to each patient's specific needs.

Global Joint Pain Injections Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

The global Joint Pain Injections market is experiencing significant growth due to the rising prevalence of joint-related conditions and the increasing demand for minimally invasive treatment options. Joint pain injections offer targeted pain relief by delivering medications directly to the affected joints, providing patients with relief from pain and improving their overall quality of life. The market is driven by factors such as the aging population, the growing incidence of arthritis and other joint disorders, and advancements in injection technologies. Additionally, the market is witnessing advancements in regenerative medicine and the development of new injectable therapies. However, the market also faces challenges such as regulatory constraints, product recalls, and the high cost of treatment. Overall, the Joint Pain Injections market holds promising opportunities for growth and innovation in the healthcare industry.

Report Metric Details
Market size value in 2023 USD 6.3 billion
Market size value in 2031 USD 12.28 billion
Growth Rate 7.7%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), stem cells, and others
  • Application
    • osteoarthritis, rheumatoid arthritis, gout, and other joint-related disorders
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Novartis AG (Switzerland)
  • Eli Lilly and Company (United States)
  • Merck & Co., Inc. (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Roche Holding AG (Switzerland)
  • AbbVie Inc. (United States)
  • AstraZeneca plc (United Kingdom)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bayer AG (Germany)
  • Boehringer Ingelheim International GmbH (Germany)
  • Bristol-Myers Squibb Company (United States)
  • Celgene Corporation (United States)
  • Gilead Sciences, Inc. (United States)
  • Grünenthal GmbH (Germany)
  • Mylan N.V. (United States)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Takeda Pharmaceutical Company Limited (Japan)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Joint Pain Injections Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Joint Pain Injections Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Joint Pain Injections Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Joint Pain Injections Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Joint Pain Injections Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Joint Pain Injections Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Joint Pain Injections Market size was valued at USD 6.3 billion in 2022 and is poised to grow from USD 6.79 billion in 2023 to USD 12.28 billion by 2031, growing at a CAGR of 7.7% in the forecast period (2024-2031).

The global Joint Pain Injections market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Joint Pain Injectionss. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. 'Johnson & Johnson (United States)', ' Pfizer Inc. (United States)', ' Sanofi (France)', 'Novartis AG (Switzerland)', 'Eli Lilly and Company (United States)', 'Merck & Co., Inc. (United States)', 'GlaxoSmithKline plc (United Kingdom)', 'Roche Holding AG (Switzerland)', 'AbbVie Inc. (United States)', 'AstraZeneca plc (United Kingdom)', 'Teva Pharmaceutical Industries Ltd. (Israel)', 'Bayer AG (Germany)', 'Boehringer Ingelheim International GmbH (Germany)', 'Bristol-Myers Squibb Company (United States)', 'Celgene Corporation (United States)', 'Gilead Sciences, Inc. (United States)', 'Grünenthal GmbH (Germany)', 'Mylan N.V. (United States)', 'Sun Pharmaceutical Industries Ltd. (India)', 'Takeda Pharmaceutical Company Limited (Japan)'

One driver of the global Joint Pain Injections market is the growing prevalence of joint-related disorders. The increasing incidence of conditions such as osteoarthritis and rheumatoid arthritis has created a substantial demand for effective pain management solutions, including joint pain injections. The rising aging population, sedentary lifestyles, and sports-related injuries further contribute to the market growth.

One key market trend in the global Joint Pain Injections market is the increasing adoption of minimally invasive procedures. Patients and healthcare providers are increasingly seeking non-surgical alternatives for managing joint pain, which has led to the growing popularity of injections as a treatment option. Minimally invasive procedures, such as joint pain injections, offer several advantages, including shorter recovery times, reduced risk of complications, and less postoperative pain. These injections, which can be administered in outpatient settings, provide targeted pain relief by delivering medications directly to the affected joint. The trend towards minimally invasive procedures aligns with the growing demand for personalized and patient-centric care, as it allows for individualized treatment plans tailored to each patient's specific needs.

One dominant region in the global Joint Pain Injections market is North America. This region holds a significant share in the market due to the presence of advanced healthcare infrastructure, high healthcare expenditure, and a large patient population suffering from joint-related disorders. The region also benefits from the availability of advanced treatment options and the presence of key market players.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Joint Pain Injections Market

Product ID: SQMIG35I2165

$5,300
BUY NOW GET FREE SAMPLE